Why does nuclear magnetic resonance spectroscopy detect fewer metabolites than mass spectrometry in many samples?
In the field of metabolomics, nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) are the two primary, complementary analytical methods.
NMR is highly valued for its ability to provide detailed information on molecular structure while preserving the integrity of the sample. However, it detects fewer metabolites than mass spectrometry primarily because it has limited sensitivity. Due to this inherent limitation, NMR typically yields data on only a relatively small number of metabolites in most biological samples.1
In contrast, MS-based techniques are noted for their impressive sensitivity and specificity, allowing for the detection of a broader range of metabolites. While MS is a powerful tool, it is not without its own challenges; it often requires extensive sample preparation, and the chemical diversity of the metabolome can complicate the extraction process, as protocols optimized for hydrophilic substances may not effectively recover more hydrophobic or oily molecules.1